Does cancer risk increase with HbA1c, independent of diabetes?

被引：0
|
作者：
J C de Beer
L Liebenberg
机构：
[1] Center for Research and Continued Engineering Development,
[2] North-West University (Pretoria Campus),undefined
[3] Suite No. 91,undefined
[4] Private Bag X30,undefined
[5] Lynnwood Ridge,undefined
[6] Pretoria 0040,undefined
[7] South Africa,undefined
[8] TEMM International (Pty) Ltd,undefined
来源：
British Journal of Cancer | 2014年 / 110卷
关键词：
cancer prevention; HbA; diabetes; cancer risk; pre-diabetes; hyperglycaemia;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2361 / 2368
页数：7
相关论文
共 50 条
  • [41] HbA1c as a risk factor for retinopathy and nephropathy in persons with type 1 diabetes
    Ludvigsson, J.
    Pivodic, A.
    Svensson, A. -M.
    Olafsdottir, A. F.
    Wedel, H.
    Lind, M.
    DIABETOLOGIA, 2019, 62 : S499 - S500
  • [42] HbA1c as a predictor of diabetes after gestational diabetes
    Claesson, R.
    Ignell, C.
    Shaat, N.
    Berntorp, K.
    DIABETOLOGIA, 2016, 59 : S455 - S455
  • [43] HbA1c: a useful cardiovascular risk marker in those without diabetes?
    Preiss, D.
    Sattar, N.
    DIABETOLOGIA, 2010, 53 (12) : 2468 - 2469
  • [44] HbA1c: a useful cardiovascular risk marker in those without diabetes?
    D. Preiss
    N. Sattar
    Diabetologia, 2010, 53 : 2468 - 2469
  • [45] First Trimester HbA1c and Gestational Diabetes (GDM) Risk Prediction
    Hinkle, Stefanie N.
    Tsai, Michael
    Rawal, Shristi
    Grewal, Jagteshwar
    Zhang, Cuilin
    DIABETES, 2017, 66 : A391 - A391
  • [46] HbA1c in CVD risk prediction
    Kang, Seema
    LANCET DIABETES & ENDOCRINOLOGY, 2014, 2 (05): : 366 - 366
  • [47] Effects of finerenone in people with chronic kidney disease and type 2 diabetes are independent of HbA1c at baseline, HbA1c variability, diabetes duration and insulin use at baseline
    McGill, Janet B.
    Agarwal, Rajiv
    Anker, Stefan D.
    Bakris, George L.
    Filippatos, Gerasimos
    Pitt, Bertram
    Ruilope, Luis M.
    Birkenfeld, Andreas L.
    Caramori, Maria L.
    Brinker, Meike
    Joseph, Amer
    Lage, Andrea
    Lawatscheck, Robert
    Scott, Charlie
    Rossing, Peter
    FIDELIO-DKD Investigator
    FIGARO-DKD Investigator
    DIABETES OBESITY & METABOLISM, 2023, 25 (06): : 1512 - 1522
  • [48] The risk of clinical misinterpretation of HbA1c: Modelling the impact of biological variation and analytical performance on HbA1c used for diagnosis and monitoring of diabetes
    Weykamp, Cas
    Siebelder, Carla
    Lenters, Erna
    Slingerland, Robbert
    English, Emma
    CLINICA CHIMICA ACTA, 2023, 548
  • [49] HbA1c Knowledge in Adults with Type 1 Diabetes: Does Patient Accuracy Matter?
    Hessler, Danielle M.
    Fisher, Lawrence
    Polonsky, William H.
    Masharani, Umesh
    Strycker, Lisa
    Blumer, Ian
    Peters, Anne L.
    Bowyer, Vicky
    DIABETES, 2016, 65 : A209 - A209
  • [50] FPG and HbA1c are independent risk factors for microvascular but not macrovascular complications in newly diagnosed type 2 diabetes
    Kim, JI
    Stevens, RJ
    Holman, RR
    DIABETOLOGIA, 2005, 48 : A33 - A33
12345